220 results on '"Kuzel T"'
Search Results
2. XIV. T- and NK-cell lymphoproliferative disorders
3. CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
4. Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
5. Quality of life in low-income patients with metastatic prostate cancer: Divergent and convergent validity of three instruments
6. Angiostatin4.5: From the Bench To The Bedside: ID: 276
7. Efficacy, survival, and toxicity of retinoids in the management of cutaneous T-cell lymphoma
8. Cutaneous T-Cell Lymphomas
9. A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon α-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population
10. P2.04-69 Impact of Antibiotic Usage on Survival During Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer (NSCLC)
11. Matched whole-genome sequencing and whole-exome sequencing with circulating tumor DNA (ctDNA) analysis are complementary modalities in clinical practice
12. Eosinophilia Protects Against S. Aureus Systemic and Pneumonia Induced Bacteremia
13. Testicular Cancer
14. 2028P - Matched whole-genome sequencing and whole-exome sequencing with circulating tumor DNA (ctDNA) analysis are complementary modalities in clinical practice
15. THE BUILDING RESEARCH CAPACITY (BRC) INITIATIVE: TO BE LAUNCHED AT THE 2016 ANNUAL NAPCRG MEETING
16. BUILDING RESEARCH & SCHOLARSHIP CAPACITY IN DEPARTMENTS OF FAMILY MEDICINE: A NEW JOINT ADFM-NAPCRG INITIATIVE
17. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
18. 501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
19. Randomized, Dose-Ranging Phase Ii Trial of Nivolumab for Metastatic Renal Cell Carcinoma (Mrcc)
20. A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl)
21. CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
22. IN PURSUIT OF A TRANSFORMED HEALTH CARE SYSTEM: FROM PATIENT CENTERED MEDICAL HOMES TO ACCOUNTABLE CARE ORGANIZATIONS AND BEYOND
23. Safety and efficacy of sequencing high-dose interleukin 2 (IL2) after tyrosine kinase inhibitor (TKI) therapy for metastatic renal cell carcinoma.
24. Correlates of capillary leak syndrome (CLS) in patients with cutaneous T-cell lymphoma (CTCL) during treatment with denileukin diftitox (DD) in a placebo (PBO)-controlled phase III trial.
25. An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with hormone refractory prostate cancer (HRPC)
26. Hand foot skin reaction (HFSR) by the multikinase inhibitors (MKIs) sorafenib and sunitinib: Impact on quality of life (QoL)
27. A phase I study of the oral platinum agent satraplatin (S) in with capecitabine (C) in patients (pts) with advanced solid malignancies
28. A Phase I/II Study of External Deep Hypothermia (DHT) With Radiation Therapy (RT) and Androgen Suppression (AS) in High-Risk Prostate Cancer (HR PC)
29. ID: 276 Angiostatin4.5: From the Bench To The Bedside
30. Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial
31. Treg depletion with denileukin difititox (DD) enhances lymphocytosis and eosinphilia in patients treated with high-dose IL-2 (HDIL-2) for metastatic renal cell cancer (MRCC)
32. Hematologic malignancies developing in previously healthy individuals who received hematopoietic growth factors: Implications for use of colony stimulating factors in healthy volunteers participating in early phase clinical studies and in healthy blood product donors
33. A multicenter phase II study of thalidomide in combination with interleukin-2 (IL-2) in patients with previously untreated metastatic renal cell carcinoma (MRCC)
34. Relationship between biological and self-reported measures of stress among informal caregivers of patients with prostate cancer
35. Phase II study of denileukin diftitox for previously treated low grade non-Hodgkin’s lymphoma: E1497 final report
36. Disproportionately high fatality rate of women compared to men in patients with gemcitabine-associated lung injury: Preliminary findings from RADAR
37. Obstacles to evaluation of adverse drug events (ADEs) occurring during pharmaceutical sponsored clinical trials of new cancer drugs: Preliminary findings from the RADAR/IRB study
38. Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC)
39. Gemcitabine-associated interstitial pneumonitis: Comprehensiveness and clinical characteristics of FDA and medical literature cases
40. 810O - Randomized, Dose-Ranging Phase Ii Trial of Nivolumab for Metastatic Renal Cell Carcinoma (Mrcc)
41. ONTAK (DAB389IL-2)
42. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
43. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
44. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.
45. 1152 Gemcitabine in the treatment of patients with advanced transitional cell carcinoma: A phase II study
46. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
47. 2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.
48. Suppression of Anti-Interferon -2a Antibody Formation in Patients With Mycosis Fungoides by Exposure to Long-Wave UV Radiation in the A Range and Methoxsalen Ingestion
49. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.
50. Interferon Alfa-2a Combined With Phototherapy in the Treatment of Cutaneous T-Cell Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.